Rare lephants
Screener

Filana Therapeutics, Inc.

FLNA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 20, 2026 FORM 8-K
4 Oct 1, 2026 FORM 4
4 Sep 30, 2026 FORM 4
8-K Sep 22, 2026 FORM 8-K
8-K Sep 18, 2026 FORM 8-K
10-Q Jul 29, 2026 FORM 10-Q
8-K Jul 29, 2026 FORM 8-K
8-K Jun 15, 2026 FORM 8-K
10-Q May 7, 2026 FORM 10-Q
8-K May 7, 2026 FORM 8-K
ARS Apr 28, 2026 FORM ARS
DEF 14A Apr 28, 2026 FORM DEF 14A
8-K Apr 28, 2026 FORM 8-K
10-K Mar 12, 2026 FORM 10-K
8-K Mar 12, 2026 FORM 8-K
8-K Mar 10, 2026 FORM 8-K
8-K Feb 19, 2026 FORM 8-K
8-K Dec 23, 2025 FORM 8-K
8-K/A Dec 22, 2025 FORM 8-K/A
8-K Dec 18, 2025 FORM 8-K
8-K Dec 17, 2025 FORM 8-K
EFFECT Dec 5, 2025
424B2 Dec 5, 2025 424B2
CORRESP Dec 3, 2025
8-K Dec 3, 2025 FORM 8-K
← Newer Page 1 of 49 · 1217 filings Older →